T
Tempest Therapeutics D
D
TPST
1.04000
USD
-0.01
(-0.95%)
Market Open
Volume
15,263
EPS
0
Div Yield
0
P/E
-1
Market Cap
26,216,104
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Tempest Therapeutics
Sector: Healthcare
Industry: Biotechnology
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.